RESEARCHER PROFILE

Ramon L. Corbalan

← Back to Pontificia Universidad Católica de Chile

R

Pontificia Universidad Católica de Chile

Acute Myocardial Infarction ResearchAtrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementCoronary Interventions and DiagnosticsHeart Failure Treatment and Management

Ramon L. Corbalan works in Acute Myocardial Infarction Research, Atrial Fibrillation Management and Outcomes, Acute Ischemic Stroke Management, Coronary Interventions and Diagnostics, Heart Failure Treatment and Management. Recorded institutional associations include Pontificia Universidad Católica de Chile, Advanced Center for Chronic Diseases, University of Chile.

206Publications
5,647Citations
35H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

    2011 · 1,252 citations
  2. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus

    2017 · 430 citations
  3. Ticagrelor in Patients with Stable Coronary Disease and Diabetes

    2019 · 366 citations
  4. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis

    2008 · 259 citations
  5. VCAM-1 as a predictor biomarker in cardiovascular disease

    2021 · 224 citations
  6. Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release

    1976 · 175 citations
  7. Psychological stress and ventricular arrhythmias during myocardial infarction in the conscious dog

    1974 · 174 citations
  8. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction

    2016 · 168 citations
  9. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial

    2014 · 163 citations
  10. Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry

    2016 · 157 citations
  11. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials

    2009 · 129 citations
  12. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation

    2018 · 105 citations
  13. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

    2018 · 93 citations
  14. Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF‐TIMI 48 Trial

    2016 · 82 citations
  15. Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group

    2019 · 76 citations
  16. Impaired cardiac autophagy in patients developing postoperative atrial fibrillation

    2011 · 74 citations
  17. Assessment of Left Atrial Function in Hypertrophic Cardiomyopathy and Athlete's Heart: A Left Atrial Myocardial Deformation Study

    2012 · 65 citations
  18. Risk factors for systemic embolism in patients with paroxysmal atrial fibrillation

    1992 · 60 citations
  19. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

    2019 · 59 citations
  20. C-reactive protein and atrial fibrillation: “Evidence for the presence of inflammation in the perpetuation of the arrhythmia”

    2005 · 56 citations
  21. Global Variation in the Prevalence of Elevated Cholesterol in Outpatients With Established Vascular Disease or 3 Cardiovascular Risk Factors According to National Indices of Economic Development and Health System Performance

    2012 · 53 citations
  22. Left Atrial Dysfunction Is a Predictor of Postcoronary Artery Bypass Atrial Fibrillation: Association of Left Atrial Strain and Strain Rate Assessed by Speckle Tracking

    2011 · 51 citations
  23. Administration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function, exercise capacity, and neurohormonal status

    2003 · 50 citations
  24. Systemic vascular cell adhesion molecule-1 predicts the occurrence of post-operative atrial fibrillation

    2010 · 44 citations
  25. Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: Results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial

    2001 · 43 citations

← Return to the university profile